Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S303000, C514S305000, C514S299000, C546S119000, C546S121000, C546S123000, C546S153000, C546S156000
Reexamination Certificate
active
07902226
ABSTRACT:
3-(1-Aminocycloalkyl)pyrrolidinyl-substituted-6-dehalodeno(hydrogen-substituted)quinolon carboxylic acid derivatives having specific substituents as represented by the following formula (I), its salts, and hydrates thereof exhibit a broad and potent antibacterial activity on gram-negative and gram-positive bacteria, in particular, resistant bacteria typified by gram-positive cocci, including MRSA, PRSP and VRE. Thus these compounds are usable as drugs.
REFERENCES:
patent: 5098912 (1992-03-01), Hayakawa et al.
patent: 5476950 (1995-12-01), Hayakawa et al.
patent: 5849757 (1998-12-01), Takemura et al.
patent: 5910498 (1999-06-01), Yazaki et al.
patent: 5998436 (1999-12-01), Yazaki et al.
patent: 6121285 (2000-09-01), Takemura et al.
patent: 6184388 (2001-02-01), Takemura et al.
patent: 6391889 (2002-05-01), Takemura et al.
patent: 6448266 (2002-09-01), Takemura et al.
patent: 6462040 (2002-10-01), Takemura et al.
patent: 6949662 (2005-09-01), Takemura et al.
patent: 2002/0077345 (2002-06-01), Takemura et al.
patent: 0 807 630 (1997-11-01), None
patent: 0 911 328 (1999-04-01), None
patent: 0 919 553 (1999-06-01), None
patent: 0 924 213 (1999-06-01), None
patent: 0 977 328 (2000-02-01), None
patent: 0 995 744 (2000-04-01), None
patent: 1 020 459 (2000-07-01), None
patent: 10-81682 (1998-03-01), None
patent: 3760172 (2006-01-01), None
patent: WO 97/19072 (1997-05-01), None
patent: WO 98/54169 (1998-03-01), None
patent: WO 98/52939 (1998-11-01), None
patent: 9854169 (1998-12-01), None
patent: WO 99/14214 (1999-03-01), None
patent: 00/31062 (2000-06-01), None
Israeli Office Action dated Dec. 10, 2007.
Rejection on a JP application, pp. 1-11, mailed Nov. 4, 2004.
Koichi Yabe, et al., “Safety evaluation of antibacterial drugs (single intravenous dose toxicity study in mice)”, New Product Research Laboratories I, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan, prepared on Aug. 28, 2000 for internal distribution only.
Koichi Yabe, et al., “Safety evaluation of antibacterial drugs (micronucleus test of quinolones in mice)”, New Product Research Laboratories I, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan, prepared on Oct. 25, 2000 for internal distribution only.
Satoru Ito, et al., “Micronucleus test of D01-5816d in rats (confirmation study)”, Drug Safety Research Laboratory, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan, prepared on Feb. 2001 for internal distribution only.
Hayashizaki (Igarashi), “Rapid report of early safety evaluation (field: antibacterial drugs)”, prepared on Mar. 6, 2003 for internal distribution only.
Nakayama (Igarashi), “Rapid report of early safety evaluation (field: antibacterial drugs)”, prepared on Sep. 11, 2003 for internal distribution only.
Katsuko Fujikawa, et al., “In Vitro Antibacterial Activity of DX-619, a Novel Des-Fluoro(6) Quinolone”, Antimicrobial Agents and Chemotherapy, Jul. 2005, p. 3040-3045, vol. 49, No. 7.
Katsuko Fujikawa, et al., “DX-619: Antibacterial activity against clinical isolates”, New Product Research Laboratories I, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan, prepared on Feb. 12, 2004 for internal distribution only.
Investigator's Brochure DX-619, Daiichi Pharmaceutical Co. & Ltd., Feb. 5, 2007, p. 64-70.
Exhibit A: Data Summary, prepared on Mar. 2007 for purposes of accompanying IDS.
Exhibit B: Data Summary, prepared on Mar. 2007 for purposes of accompanying IDS.
Hayakawa Isao
Itoh Masao
Miyauchi Rie
Takahashi Hisashi
Takemura Makoto
Daiichi Pharmaceutical Co. Ltd.
Seaman D. Margaret
Sughrue & Mion, PLLC
LandOfFree
Dehalogeno-compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dehalogeno-compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dehalogeno-compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2769973